Please login to the form below

Not currently logged in

Excellence in Healthcare Collaboration and Partnerships

Sponsored by

Back to Results

Highly Commended

Treat to Target

AbbVie with support from Lucid

Summary of work

"An excellent initiative that has brought together the voices of RA patients, healthcare professionals and commissioners." National Rheumatoid Arthritis Society

Rheumatoid arthritis (RA) can cause irreversible joint damage and affects more than 690,000 UK adults. Treat to Target (T2T) represents an important advance providing clear direction on tight RA control. A previous T2T education programme, led by a UK Steering Committee (SC), was awarded Communiqué and PMEA awards in 2012.

To drive T2T in today’s NHS, we embarked on a journey to change clinical behaviour. Qualitative expert interviews revealed barriers to T2T and highlighted the need for a collaborative approach, including RA patients, commissioners and healthcare professionals.

Underpinned by an evidence-based model for changing clinician behaviour, we developed a multifaceted programme that engaged all stakeholders:

  • Multicentre T2T audit: assessing current practice and providing outcomes data for commissioners
  • T2T CONNECT: advancing HCP-patient communication
  • Rheumatologist-commissioner co-creation workshops: formulating solutions to organisational barriers
  • T2T Summit: including peer-to-peer Experience Exchange.

Interim results of the audit demonstrated a positive impact of T2T awareness. Following our multi-stakeholder programme a survey of 192 rheumatologists showed improved T2T implementation vs preliminary audit findings, specifically around monitoring disease activity (44% to 76%) and appropriate treatment escalation (72% to 83%).

Judges comments

This programme was evolved – it was well designed and well implemented. It is multifunctional and shows a wider scale of collaboration that is supported and therefore sustainable. Through improved stakeholder engagement it led to patients, HCPs and CCGs working towards a common goal of improving outcomes in rheumatoid arthritis. It genuinely changed the way people behaved in consultations.


Leicester City TotalCare COPD Service - Spirit Healthcare Ltd

Highly commended

Treat to Target - AbbVie with support from Lucid


Helping foster an unlikely partnership between, Endocrinologists, Nephrologists and Oncologists: the European Hyponatraemia Network (EHN) - Otsuka Pharmaceutical Europe Ltd with support from apothecom (a Huntsworth Health company)

Take Action for World Diabetes Day - Sanofi Diabetes with support from Havas Life Medicom

Key dates

Entry deadline 25 August 2023
Extended entry deadline 1 September 2023*
*additional fee applies
Judging Day 10 October 2023
Company/Team of the Year Interviews 3 November 2023
PMEA Event 22 November 2023